The life sciences industry has lacked a future-proofing strategy to scale automation beyond processes or steps within processes such as task automation. Most pharma companies today are making large investments in automation to combat rising costs, time, and regulations in drug discovery, supply chain, and manufacturing. But the industry is still considered to be lagging in institutionalizing a well-defined strategy to integrate hyper-automation into the ecosystem to deliver transformational impact to customer experience and drive better business outcomes.
In this webcast, a panel of thought leaders and experts will take a deep dive into the hows and whys of implementing intelligent automation in a life sciences business. Discover how biopharma and life sciences companies can genuinely maximize their automation efforts by going beyond their typical task automation strategy.
Key topics include:
- Hyper-Automation Adoption Challenges and Trends in the Pharma Industry
- Shifting from Task Led Automation to a Transformational Automation Strategy
- Cost Management of Operational Maintenance Through Intelligent Automation